Life Science Investing Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
Life Science Investing Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value Creation
Life Science Investing Royalty Pharma Announces Release of Deloitte's Report on the Biopharma Royalty Market
Life Science Investing Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Surface Metals Inc. Provides Corporate Update: Gold's 2025 Rally Amplifies Cimarron Gold Project Potential and Strengthens Strategic Position
Bold Ventures Provides Recent News at Koper Lake in the Ring of Fire and Burchell Gold and Copper Project
Kobo Resources Intersects 10.0 m at 2.50 g/t Au and 13.0 m at 1.49 g/t Au, Confirming Strong Gold Mineralisation Along the Contact Zone Fault at Kossou
